Canada’s Aurinia Pharmaceuticals will report positive results from its 48-week AURION clinical trial evaluating voclosporin for lupus nephritis (LN) treatment. The presentation will take place at the 12th International Congress on Systemic Lupus Erythematosus (LUPUS 2017) & the 7th Asian Congress on Autoimmunity (ACA 2017), to be held March 26-29 in Melbourne,…
The Lupus Foundation of America (LFA) has received the 2017 Paul G. Rogers Distinguished Organization Advocacy Award from Research!America for advancing research, education, support and advocacy programs for lupus. The Rogers Award series recognizes public or private organizations that advocate for medical or health research at…
Patients with new-onset lupus erythematosus (SLE) have high levels of autoantibodies against programmed cell death protein 1 (PD-1), an immune response co-inhibitor, new research from China shows. The study, “Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic…
Researchers from the European League Against Rheumatism (EULAR) have published a list of recommendations that women with lupus or antiphospholipid syndrome (APS) can use to deal with health issues or do family planning. The article, “EULAR Recommendations For Women’s Health And The Management Of Family Planning, Assisted Reproduction, Pregnancy And…
Actress, singer, and celebrity Selena Gomez, who came forward about her own struggles with lupus in 2015, has made a donation to the Keck School of Medicine of the University of Southern California (USC) to support new lupus research. While Gomez has been an important voice for the cause,…
The U.S. House of Representatives has passed a bill authorizing $5 million a year for new lupus research under the Congressionally Directed Medical Research Program, operated by the Army Medical Research and Materiel Command in Ft. Detrick, Maryland. The U.S. Senate will now consider the legislation. If passed, it will become law, allowing…
Neovacs will present an update on the company’s interferon alpha (IFNα) Kinoid vaccine program for lupus, dermatomyositis and type 1 diabetes at the upcoming 2017 Keystone Symposia Conference taking place in Banff, Alberta, Canada. Géraldine Grouard-Vogel, PhD, the company’s chief scientific officer, is set to give the  presentation — “Overexpression of IFNalpha…
About 54 million Americans have been diagnosed with arthritis — a debilitating joint disease that takes many forms including lupus and rheumatoid arthritis — and 24 million are disabled by some sort of the disease. That means one in four Americans is living with the disease today, up 20 percent since 2002,…
Scientists at Chicago’s Rush University Medical Center have discovered a small molecule that can significantly ameliorate symptoms in systemic lupus erythematosus (SLE) patients who carry a defective CD11b protein. The findings suggest that pharmacologic activation of CD11b is a potential new therapeutic strategy for SLE. The study, “CD11b…
A new study reports that eculizumab may be effective in the treatment of certain patients with systemic lupus erythematous (SLE) with renal (kidney) involvement, a condition called lupus nephritis (LN). In the study, “Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence,” published in the journal Rheumatology…